Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.
2.

Multiple pathways to tumor immunity and concomitant autoimmunity.

Turk MJ, Wolchok JD, Guevara-Patino JA, Goldberg SM, Houghton AN.

Immunol Rev. 2002 Oct;188:122-35. Review.

PMID:
12445286
3.

Immunotherapeutic potential of whole tumour cells.

Ward S, Casey D, Labarthe MC, Whelan M, Dalgleish A, Pandha H, Todryk S.

Cancer Immunol Immunother. 2002 Sep;51(7):351-7. Epub 2002 Jun 14. Review.

PMID:
12192534
4.

Immunity to melanoma antigens: from self-tolerance to immunotherapy.

Slingluff CL Jr, Chianese-Bullock KA, Bullock TN, Grosh WW, Mullins DW, Nichols L, Olson W, Petroni G, Smolkin M, Engelhard VH.

Adv Immunol. 2006;90:243-95. Review.

PMID:
16730266
5.

Peptide-based cancer vaccines.

Melief CJ, Offringa R, Toes RE, Kast WM.

Curr Opin Immunol. 1996 Oct;8(5):651-7. Review.

PMID:
8902390
6.

DNA minigene vaccination for adjuvant neuroblastoma therapy.

Lode HN, Huebener N, Zeng Y, Fest S, Weixler S, Gaedicke G.

Ann N Y Acad Sci. 2004 Dec;1028:113-21. Review.

PMID:
15650237
7.

Influence of p53 on anti-tumor immunity (review).

Bueter M, Gasser M, Lebedeva T, Benichou G, Waaga-Gasser AM.

Int J Oncol. 2006 Feb;28(2):519-25. Review.

PMID:
16391808
8.

Tumors as elusive targets of T-cell-based active immunotherapy.

Marincola FM, Wang E, Herlyn M, Seliger B, Ferrone S.

Trends Immunol. 2003 Jun;24(6):335-42. Review.

PMID:
12810110
9.

Immunity to cancer through immune recognition of altered self: studies with melanoma.

Guevara-PatiƱo JA, Turk MJ, Wolchok JD, Houghton AN.

Adv Cancer Res. 2003;90:157-77. Review.

PMID:
14710950
10.

Transcriptional analysis of tumor-specific T-cell responses in cancer patients.

Nagorsen D, Wang E, Marincola FM, Even J.

Crit Rev Immunol. 2002;22(5-6):449-62. Review.

PMID:
12803321
11.

De-immunization of therapeutic proteins by T-cell epitope modification.

De Groot AS, Knopp PM, Martin W.

Dev Biol (Basel). 2005;122:171-94. Review.

PMID:
16375261
12.

Epitope dominance, competition and T cell affinity maturation.

Kedl RM, Kappler JW, Marrack P.

Curr Opin Immunol. 2003 Feb;15(1):120-7. Review. No abstract available.

PMID:
12495743
13.

Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma.

Ray S, Chhabra A, Mehrotra S, Chakraborty NG, Ribas A, Economou J, Mukherji B.

Clin Dermatol. 2009 Nov-Dec;27(6):603-13. doi: 10.1016/j.clindermatol.2008.09.019. Review.

PMID:
19880048
14.

Immunomics: discovering new targets for vaccines and therapeutics.

De Groot AS.

Drug Discov Today. 2006 Mar;11(5-6):203-9. Review.

PMID:
16580597
15.

From defined human tumor antigens to effective immunization?

Boon T, Gajewski TF, Coulie PG.

Immunol Today. 1995 Jul;16(7):334-6. Review. No abstract available.

PMID:
7576068

Supplemental Content

Support Center